RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Apex Biotechnology - Stock

Apex Biotechnology Equity 2024

Apex Biotechnology Equity

1.8 B TWD

Ticker

1733.TW

ISIN

TW0001733004

In 2024, Apex Biotechnology's equity was 1.8 B TWD, a -1.15% increase from the 1.82 B TWD equity in the previous year.

Apex Biotechnology Aktienanalyse

What does Apex Biotechnology do?

Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Apex Biotechnology's Equity

Apex Biotechnology's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Apex Biotechnology's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Apex Biotechnology's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Apex Biotechnology's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Apex Biotechnology’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Apex Biotechnology Stock

What is the equity of Apex Biotechnology this year?

Apex Biotechnology has equity of 1.8 B TWD this year.

What was the equity of Apex Biotechnology compared to the previous year?

The equity of Apex Biotechnology has increased/decreased by -1.15% decreased compared to the previous year.

What impact does a high equity have on investors of Apex Biotechnology?

A high equity is advantageous for investors of Apex Biotechnology as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Apex Biotechnology?

A low equity can be a risk for investors of Apex Biotechnology, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Apex Biotechnology affect the company?

An increase in equity of Apex Biotechnology can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Apex Biotechnology affect the company?

A reduction in equity of Apex Biotechnology can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Apex Biotechnology?

Some factors that can affect the equity of Apex Biotechnology include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Apex Biotechnology so important for investors?

The equity of Apex Biotechnology is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Apex Biotechnology take to change the equity?

To change equity, Apex Biotechnology can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Apex Biotechnology pay?

Over the past 12 months, Apex Biotechnology paid a dividend of 1.4 TWD . This corresponds to a dividend yield of about 4.02 %. For the coming 12 months, Apex Biotechnology is expected to pay a dividend of 1.4 TWD.

What is the dividend yield of Apex Biotechnology?

The current dividend yield of Apex Biotechnology is 4.02 %.

When does Apex Biotechnology pay dividends?

Apex Biotechnology pays a quarterly dividend. This is distributed in the months of September, July, July, June.

How secure is the dividend of Apex Biotechnology?

Apex Biotechnology paid dividends every year for the past 21 years.

What is the dividend of Apex Biotechnology?

For the upcoming 12 months, dividends amounting to 1.4 TWD are expected. This corresponds to a dividend yield of 4.02 %.

In which sector is Apex Biotechnology located?

Apex Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apex Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apex Biotechnology from 6/14/2024 amounting to 1.1 TWD, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Apex Biotechnology pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of Apex Biotechnology in the year 2023?

In the year 2023, Apex Biotechnology distributed 1.3 TWD as dividends.

In which currency does Apex Biotechnology pay out the dividend?

The dividends of Apex Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Apex Biotechnology

Our stock analysis for Apex Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apex Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.